Introduction
Cardiovascular disease (CVD) is a leading cause of death and a major driver of graft loss in kidney transplant recipients (KTRs) 1 . Conventional cardiovascular risk factors incompletely explain the increased incidence of cardiovascular events in KTRs 2 , and several studies have highlighted the potential contributions of non-traditional exposures [2] [3] [4] . Inflammation and immune reactivity are believed to provoke atherogenesis in the general population 5 , whilst inflammation correlates with endothelial dysfunction and accelerated atherosclerosis in general 6 and chronic kidney disease (CKD) [6] [7] [8] [9] populations. Although less studied in KTRs, recent evidence confirms that inflammation is an important and reproducible risk factor for cardiovascular events, all-cause mortality, and graft failure among KTRs 2,10-15 .
Despite its undisputed clinical significance, factors contributing to inflammation in KTRs remain under-investigated. It is also unclear whether such adverse outcomes are due to inflammation per se, or whether it reflects the underlying drivers of inflammatory processes.
Abdominal obesity and smoking were identified in one study as important modifiable determinants of inflammation among KTRs 12 , but aside from this, data in kidney transplantation remains limited. Yet studies in general and other diseased populations have identified important factors contributing to inflammation and endothelial dysfunction, with the role of systemic endotoxemia in this context having received attention recently.
Endotoxemia is characterised by the presence of endotoxins in the blood. Endotoxin, also known as Lipid A, is a core component of lipopolysaccharide (LPS) found in the outer cell 4 membrane of the cell wall of Gram-negative bacteria that reside in the intestinal lumen as part of gut microbiota 16 . Upon release into the circulation, LPS stimulates the release of proinflammatory cytokines and expression of surface adhesion molecules such as CD14 on inflammatory cells, resulting in the 'syndrome' of systemic inflammation 17 . In vitro, endotoxin induces endothelial damage and activation 16 . Clinical data shows that systemic endotoxemia is associated with cardiovascular disease in the general population 18 , atherosclerosis in patients undergoing peritoneal dialysis 19 , and increased mortality risk in haemodialysis patients 20, 21 . The association between CD14 and mortality in CKD 22 and haemodialysis cohorts 23, 24 further lend support to these observations. However, the role of endotoxemia driving inflammation and endothelial damage among KTRs remains unexplored and warrants further investigation.
This study therefore set out to investigate the role of endotoxemia on inflammation and endothelial activation in clinically stable KTRs, alongside traditional cardiovascular risk factors and contemporary risk factors such as hypovitaminosis D [25] [26] [27] [28] , hyperuricemia [29] [30] [31] , hypoadiponectinemia [32] [33] [34] , and high dietary intake of fructose [35] [36] [37] . The association between endotoxemia and 5-year cardiovascular events was also assessed. Finally, determinants of endotoxemia were explored, in an attempt to shed new light on plausible interventional targets to improve cardiovascular outcome in kidney transplantation.
Methods

Participants and Study Design
5 This is a cross-sectional study with prospective follow-up from a prevalent cohort of KTRs beyond 1-year post-transplantation with stable graft function (<10% increase in serum creatinine over the preceding 6 months). Patient recruitment occurred between April 2010
and April 2013. Exclusion criteria included episodes of acute rejection within the last 6 months, evidence of sepsis in the last 6 weeks, known active malignancy or chronic infection, history of thyroid disease or adrenal insufficiency, and contraindications for use of bioimpedance-based body composition assessment (i.e. implanted or external electronic devices, metallic implants, amputations, pregnancy, and lactation). This study was approved by the local research ethics committee and was conducted in accordance with the Declaration of Helsinki.
Data Collection
Demographic and Clinical Parameters
Age, gender, ethnicity, and time post-transplantation were collected from patients' medical records. Alcohol intake (units per week) and smoking status were collected by questionnaire.
Smoking status were classified into non-smoker, ex-smoker and current smoker, with exsmokers defined as individuals who had ever smoked but did not smoke at the time of research visit, regardless of their age and length of time since quitting 38 . In addition, the following clinical parameters were retrieved from patients' medical records: 1) presence of coronary heart disease; 2) presence of diabetes, either pre-transplantation (pre-DM), or new 6 onset diabetes after transplantation (NODAT); 3) previous acute rejection episodes; 4) dialysis vintage; 5) number of kidney transplants; 6) pre-emptive transplantation; 7) use of statin; and 8) immunosuppressive medication usage, either prednisolone, calcineurin inhibitor (CNI), or adjunctive antiproliferative agent. Comorbidity was assessed by Index of Coexistent Disease (ICED) using the algorithm described by the Haemodialysis Study 39 .
Cardiovascular risk was estimated by 7-year risk for major adverse cardiac events (MACE) in kidney transplantation using a validated algorithm derived by Soveri et al 40, 41 . The required data for calculations of ICED and 7-year risk for MACE were extracted from patients' medical records.
Systolic (SBP) and diastolic (DBP) blood pressure were measured semi-recumbent with a fully automatic upper-arm digital blood pressure monitor (Spot Vital Signs LXi; Welch Allyn). Six readings over an 8-to 10-minute period were taken, with the first reading ignored, and the mean of the remaining five used for subsequent derivation of mean arterial pressure (MAP), calculated using the formula (2DBP+SBP)/3 42 .
Cardiovascular Event Data
Following data collection at initial study evaluation, time to cardiovascular event of acute origin (i.e. coronary artery disease including acute coronary syndrome or myocardial infarction; and cerebrovascular disease including transient ischaemic attack or cerebrovascular accident) was extracted from patients' medical records. Such events were 7 classified according to clinical presentation at the time of occurrence. Follow-up period was up to 5 years post initial evaluation.
Laboratory Parameters
Blood samples were taken in the morning following an overnight fast for measurements of creatinine, estimated glomerular filtration rate (eGFR; derived using four-variable modifications of diet in renal disease equation), urate, 25-hydroxyvitamn D, and full lipid profile including total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglycerides. Analyses were undertaken in the accredited hospital biochemistry laboratory.
hsCRP was measured using a Tina-quant® cardiac C-reactive protein latex high sensitive immunoturbidimetric assay (Roche Diagnostics, Basel, Switzerland). The intra-and interassay coefficients of variations were <1.3% and <5.7% respectively.
Adiponectin and sE-selectin, the latter chosen as the most specific circulating marker for endothelial activation 43 , were measured using commercially available enzyme-linked immunosorbent assay according to manufacturer's instructions. The intra-and inter-assay coefficients of variation were 3.4% and 5.7% respectively for adiponectin (Linco Ltd, USA) 44 ; and <5% and <10% respectively for sE-selectin (R&D Systems, Germany).
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Serum endotoxin was analysed using a commercially available QCL-1000 Limulus Amebocyte Lysate end point assay (Lonza, USA), which has been widely validated as detailed previously 45, 46 . The intra-and inter-assay coefficients of variation were 3.9% and 9.6% respectively 47 .
Anthropometric Measurements and Body Composition Parameters
Body weight (kg) and height (m) were measured in a standardised procedure with participants wearing light clothing without shoes. Body weight was measured using a digital scale to the nearest 0.01kg. Body height was measured using a stadiometer with the participants standing without shoes and feet together, to the nearest 0.01m. In addition, a well-validated multi-frequency bio-impedance based body composition monitor 49 (BCM, Fresenius Medical Care, Germany) was used to assess body composition.
Measurements were carried out in a standard manner while the patient was lying supine in a flat and non-conductive bed. The inbuilt physiological body composition model measures whole-body bio-impedance spectroscopy at 50 frequencies (5-1000 kHz) via electrodes placed on the wrist (proximal to the transverse) and ankle (arch on the superior side of the 9 foot). Body composition data including lean tissue index (LTI, kg/m 2 ), fat tissue index (FTI, kg/m 2 ), and volume expansion (%) were displayed after each measurement.
Dietary Intake Parameters
Fructose, dietary fibre, total fat and saturated fat intakes were estimated by a 3-day food diary, a widely accepted dietary assessment tool deemed to be valid, reliable and accurate in estimating typical and habitual nutrient intake 50, 51 . Participants were given detailed written instructions on completing an accurate dietary record for a 3-day period, which included one weekend day, within 1 week before attending the research visit. These instructions were accompanied by verbal explanation from the researcher, which included training in portion size estimation and documentation for both dining in and eating out. The dietary records were reviewed by the researcher for accuracy and completeness at the research visit. Data was entered into Dietplan 6 P3 (Forestfield Software Ltd) nutrition analysis program by the same researcher, avoiding inter-observer variation. Total intakes of all nutrients were calculated by this program.
Statistical Analysis
Statistical analyses were performed using SPSS Statistics 23 (Chicago, IL). Results were presented as mean ± standard deviation (SD) for normally distributed data or median (interquartile range, IQR) for non-normally distributed data. Independent-sample t-test was used to compare continuous data between groups.
Linear regression analysis was used to determine the associations between predictor variables and the continuously distributed outcome variables. Regression diagnostics were performed.
The continuously distributed outcome variables (hsCRP, sE-selectin and endotoxin levels) The analyses were performed in two stages. Initially, the effect of each variable was examined in a series of univariate analyses. Subsequently, the joint effect of variables was examined in a multivariate analysis, using a backwards selection procedure to derive the final model. A type 1 error rate ≤5% (p≤0.05) was considered significant. In the multivariate regression analyses, only the explanatory variables with univariate p-values of <0.20 were included.
Due to logarithmic transformation of the outcome variable, exponential of the beta coefficient has been applied, and hence beta coefficient and its associated 95% confidence interval (CI)
have been transformed and reported in the form of "Ratio". For the categorical variable, the 11 ratio of the outcome in each category was relative to the outcome of the baseline category.
For the continuous variable, unless otherwise stated, the ratio was given for one-unit increase in the explanatory variable. 
Results
Patient Characteristics
Of 138 patients approached, 10 did not participate due to work commitment (93% consent rate). Mean age was 49 ± 15 years, 56% were male, 78% were Caucasian, 29% and 9% were ex-smoker and current smoker respectively, 20% had either pre-DM or NODAT, mean eGFR was 48 ± 18 mL/min, and mean SBP and DBP were 140 ± 19 and 80 ± 10 mmHg respectively. Immunosuppressive medication usage among KTRs were: 78% on prednisolone; 91% on calcineurin inhibitor; and 87% on adjunctive antiproliferative agent.
Statin usage was 55%. ng/mL. Full details of patient characteristics of the studied population are shown in Table 1 . In addition, univariate associations between the following predictor variables and hsCRP were seen, but did not hold in the adjusted model: increasing urate concentrations (p=0.007), increased LDL (p=0.01), higher saturated fat intake (p=0.03) and increased FTI (p<0.001).
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Determinants of Inflammation (hsCRP) in KTRs
Of note, a substantial proportion of the variation in hsCRP was explained by the variables contained within the final model (R 2 =67%).
Determinants of Endothelial Activation (sE-selectin Levels) in KTRs
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Predictors of sE-selectin levels are detailed in Table 3 . Both increased endotoxin and raised hsCRP levels were independent predictors of elevated sE-selectin levels in the multivariate regression analysis (p=0.007, Figure Univariate associations with sE-selectin were also seen with decreased HDL (p=0.02), increased triglycerides (p=0.001), higher fructose intake (p=0.04), and lower LTI (p=0.004), However, these associations did not persist in the adjusted model.
The variables within the final regression model explained 47% of the variation in sE-selectin levels (R 2 =46%). Univariate associations between increased serum endotoxin concentration and decreased HDL (p=0.006), increased LDL (p<0.001), raised total cholesterol (p=0.004), higher intake of saturated fat (p=0.04), and increased FTI (p<0.02) were also seen, but did not persist in the adjusted model.
Determinants of Endotoxin Levels in KTRs
The predictor variables within the final regression model explained 46% of the variation in endotoxin levels (R 2 =46%).
Association between Endotoxemia and Cardiovascular Events
Following initial evaluation, all patients underwent prospective follow-up at the same centre for a median duration of 51 (IQR 48-58) months. Six patients suffered an acute cardiovascular event during the follow-up period (acute coronary syndrome=3; myocardial infarct=1; ischaemic cerebrovascular accident=1; new onset lower limb claudication=1).
Endotoxin levels were significantly higher in these patients compared to those without Figure 3 .
Discussion
Although the adverse impact of inflammation on patient and graft outcomes in KTRs is wellrecognised, the drivers of such inflammatory responses are incompletely understood, therefore impeding the development of therapeutic strategies. Similarly, the relationship between inflammation and vascular disease is subject to confounders by its underlying causes, many of which remain unexplored in kidney transplantation. This study aimed to clarify these relationships by exploring the plausible underlying mechanisms, pointing towards potential therapeutic targets.
This study represents the first evidence in kidney transplantation showing that endotoxemia may be a significant independent predictor of inflammation in KTRs. This finding extends the relationship observed in non-transplant CKD 20 , haemodialysis 20 , and peritoneal dialysis 19 populations. In addition, endotoxemia was identified as a possible independent risk factor for endothelial activation in this study, a novel finding in kidney transplantation.
Furthermore, this study provides preliminary insight in kidney transplantation that raised endotoxin levels may be associated with increased cardiovascular events, an effect independent of inflammation or global cardiovascular risk. However, it is important to note that the cardiovascular event rates were low in this study, therefore this finding needs to be In vitro study demonstrates the phenomenon of endotoxin-induced endothelial activation and dysfunction 16 . This is in line with the current study showing that endotoxin levels were positively correlated with levels of circulating sE-selectin, the most specific circulating marker of endothelial activation 43 , with the latter being independently associated with incident coronary artery disease and the presence of carotid atheroma in general populations 52 . The current study also extends this clinical data to a transplant cohort, whereby an association between endotoxemia and increased cardiovascular events of acute origin was observed. Importantly, this association was independent of a validated composite marker of global cardiovascular risk, as previously derived by Soveri et al 40, 41 . Pertinently, this composite marker was also independently associated with cardiovascular events, supporting the face validity of our findings. Such effect of endotoxemia observed in this study was also independent of inflammation, although a systemic inflammatory response, assessed by hsCRP, was also in itself associated with elevated sE-selectin levels. The 'inflammationindependent' effect of endotoxemia upon endothelial activation found in this study resonates with a recently described mechanism, whereby endotoxin induces endothelial cells to display fibroblast-like phenotypes resulting in endothelial fibrosis, but in the absence of an invoked immune response 53 . Nevertheless, it remains a possibility that other inflammation-related mechanisms may also lead to endothelial activation and injury. In fact, an inflammatory response was observed with increasing endotoxin concentration in the current study.
Specifically, increased hsCRP level was most evident beyond endotoxin concentration of 2.50 EU/mL. This finding is in keeping with the prior suggestion that clinically relevant endotoxemia exists at levels greater than 2.50 EU/mL 54 . Additionally, previous studies showed that endotoxin levels among healthy individuals, non-dialysis CKD, haemodialysis, and peritoneal dialysis patients were 0.01 EU/mL 19 60 . Secondly, the relationship between endotoxemia and increasing WC observed in the present study further supports the potential role of lifestyle intervention. This relationship may be explained by the effect of diet-induced obesity or genetic obesity 61 , whereby adverse changes in composition of gut microbiota were found in obese conditions, impairing gut barrier function, and hence promoting 'metabolic endotoxemia' 61 . Indeed, the mean WC measurements in the current cohort of KTRs were 105cm for males and 89cm for females, both of which were higher than the World Health Organisation cut-off points for risk of metabolic complications (>102cm for males; and >88cm for females) 62 . Therefore, strategies for targeting abdominal obesity among KTRs should be in place. Finally, the independent association between endotoxemia and lower circulating levels of 25-hydroxyvitamin D suggests that dietary supplementation and sunlight exposure may be appropriate in this setting. The inverse relationship between endotoxin and 25-hydroxyvitamin D levels is supported by data existing outside the field of kidney transplantation, whereby vitamin D deficiency leads to defective gut mucosal integrity and immunity, allowing entry of endotoxin into the systemic circulation 63 . In addition, systemic clearance of LPS is impaired due to blunting of innate immunity by low circulating vitamin D level, resulting in endotoxemia 63 . Accordingly, findings from the current study serve to generate hypotheses amendable to future testing, with interventional studies required to explore these relationships in detail. It is likely that the evaluation of enteric microbiome in kidney transplantation, which was outside the scope of the current study, may provide insight into the basic science of these findings.
Of note, increased fructose intake, reduced 25-hydroxyvitamin D levels, and increased WC also displayed associations with inflammation independent of the relationship between endotoxemia and inflammation. The mechanisms by which excessive fructose intake results in systemic inflammation are recognised 36 , but the current study represents the first to describe this possible relationship in kidney transplantation. Similarly, low vitamin D levels as possible drivers of inflammation has been described in other clinical settings 64, 65 , but not detailed in kidney transplantation. The chronic systemic inflammation of obesity, originating from local immune responses in visceral adipose tissue 66 , is recognised in kidney transplantation 12 , and further confirmed in the current study. Of interest, the reciprocal relationship between dietary fibre intake and inflammation in KTRs is a novel finding of this study; it was most evident when dietary fibre intake fell below 15g/day. This relationship is consistent with findings from the general population [67] [68] [69] . Although the mechanism is 20 incompletely elucidated, it has been suggested that dietary fibre possibly decreases lipid oxidation and downstream inflammation 67 .
Finally, the association between reduced levels of adiponectin and endothelial activation is another novel and biologically plausible finding of this study. It extends the recognised protective effects of adiponectin on endothelium from animal models and pre-clinical settings 70, 71 to kidney transplantation. Other independent predictors of endothelial activation in this study, and perhaps testament to the face validity of the current findings, included the wellrecognised cardiovascular risk factors such as increased WC, male gender and raised blood pressure, with some evidence for an effect of aging and the use of CNI. Of note, sE-selectin is considered the most specific circulating marker of endothelial health. It reflects cotemporaneous endothelial activation rather than established structural vascular disease 43, 72 .
In the context of kidney transplantation, structural vascular disease reflects a multiplicity of prior comorbidities including those accumulated during the period of CKD and dialysis, as well as ongoing endothelial injury 73 . Since the latter represented the focus of the current study, a specific endothelial activation marker (i.e. sE-selectin) was chosen for the analysis.
Interestingly, the findings from this study showed that the use of statins did not have an impact on inflammation in KTRs. The lack of anti-inflammatory effect may be accountable by the lack of lipid-lowering effect in this cohort of KTRs 74 , as implicated by the mean levels of total-and LDL-cholesterol of 5.0 mmol/L and 3.1 mmol/L respectively, despite 55% of the patient population were prescribed statin albeit at low doses. In addition, smoking is known to promote inflammation and endothelial dysfunction 75 . It is somewhat surprising that tobacco use did not associate with markers of inflammation and endothelial This study has limitations that should be acknowledged. It represents a single-centre observational experiment characterised by a small sample size and low cardiovascular event rates. Therefore, further validations are needed in larger cohorts. In addition, the use of 3-day food diary may be influenced by day-to-day and seasonal variations. The use of food frequency questionnaire should be included in future studies aiming to provide knowledge on habitual dietary intake over a longer period, enabling a more accurate assessment between the correlations of dietary intakes with inflammation, endothelial activation and endotoxemia.
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Also, the studied cohort was predominately Caucasian, and hence the findings from this study may not be generalizable to other ethnic groups. Furthermore, there is little variation in the use of immunosuppression, but such an effect helps to enhance the homogeneity of the study.
Indeed, the R 2 values generated from the multivariate statistical models demonstrate that the identified predictors are responsible for large proportions of the variation in outcome variables. Soluble and cell surface expressed CD14 levels, both of which are influenced by endotoxemia 81 , were not examined in the current study, therefore previous data 17, [22] [23] [24] describing their importance as exposures cannot be confirmed or refuted. The cross-sectional nature of this study is unable to establish causality between predictor and outcome variables;
long-term longitudinal follow-up and a detailed understanding of the basic science behind the observations found in this study is crucial.
In summary, this study demonstrates potential targets for intervention, and sets the scene for future interventional research and therapeutic strategies in KTRs. In particular, targeting endotoxemia may serve as a potent upstream intervention for the management of cardiovascular risk in these patients, potentially improving medium-and long-term clinical outcomes of kidney transplantation.
Practical Application
This study represents the first evidence in kidney transplantation showing that endotoxemia may be a significant independent predictor of inflammation and endothelial activation. It provides preliminary insight into the association between endotoxemia and cardiovascular outcome in kidney transplantation. Our findings highlight the potential relevance of endotoxemia and other unconventional cardiovascular risk factors in kidney transplantation, setting the scene for future interventional research and therapeutic strategies. Table 2 Predictors of Inflammation (hsCRP) in Kidney Transplant Recipients Table 3 Predictors of Endothelial Activation (sE-selectin) in Kidney Transplant
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